Sarda Proteins schedules board meeting on April 30, 2026 to approve audited standalone financial results for Q4 and full year FY26.
Trading window for company securities closed from April 1, 2026 and will reopen 48 hours after results declaration.
Disclosure made under SEBI LODR Regulation 29(1) requirements for board meeting intimation.